[Diabetic neuropathy--sensory abnormalities and treatment for painful neuropathy].
Suzuki
K
K
Third Department of Internal Medicine, Tohoku University School of Medicine.
Toyota
T
T
D000527:Alprostadil / Q000627:therapeutic use; D000927:Anticonvulsants / Q000627:therapeutic use; D000929:Antidepressive Agents, Tricyclic / Q000627:therapeutic use; D002648:Child; D003929:Diabetic Neuropathies / Q000378:metabolism / Q000503:physiopathology* / Q000628:therapy; D005260:Female; D006801:Humans; D006943:Hyperglycemia / Q000150:complications; D008297:Male; D008801:Mexiletine / Q000627:therapeutic use; D010146:Pain / Q000209:etiology; D059408:Pain Management; D011108:Polymers / Q000378:metabolism; D012677:Sensation; D000254:Sodium-Potassium-Exchanging ATPase / Q000378:metabolism; D014805:Vitamin B 12 / Q000627:therapeutic use
D000927:Anticonvulsants; D000929:Antidepressive Agents, Tricyclic; D011108:Polymers; C024617:polyol; D008801:Mexiletine; D000254:Sodium-Potassium-Exchanging ATPase; D000527:Alprostadil; D014805:Vitamin B 12